Atezolizumab生物仿制藥是一種Fc工程化人源化單克隆抗體,可結(jié)合PD-L1并阻斷與PD-1和B7.1受體的相互作用。Atezolizumab生物仿制藥是一種非糖基化IgG 1 κ免疫球蛋白,計算分子量為145 kDa。 Atezolizumab生物仿制藥-超低內(nèi)毒素該產(chǎn)品同種型對照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 0.1 EU/mg as determined by the LAL method 制劑:Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.